[
    [
        {
            "time": "2018-07-10",
            "orginal_text": "舜宇6月手机镜头出货量升16.5%至1.18亿件乐游科技与腾讯订立私有化独家协议",
            "features": {
                "keywords": [
                    "舜宇",
                    "手机镜头",
                    "出货量",
                    "增长",
                    "腾讯",
                    "私有化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电子制造",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "舜宇6月手机镜头出货量升16.5%至1.18亿件乐游科技与腾讯订立私有化独家协议",
            "scores": {
                "News_content": "舜宇6月手机镜头出货量升16.5%至1.18亿件乐游科技与腾讯订立私有化独家协议",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-10",
            "orginal_text": "复星拟分拆Grand Pharma在印度独立上市，提供独立融资平台",
            "features": {
                "keywords": [
                    "复星",
                    "Grand Pharma",
                    "分拆",
                    "印度",
                    "上市",
                    "融资平台"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星拟分拆Grand Pharma在印度独立上市，提供独立融资平台",
            "scores": {
                "News_content": "复星拟分拆Grand Pharma在印度独立上市，提供独立融资平台",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-10",
            "orginal_text": "复星医药及复星国际：Grand Pharma在印度提交非正式招股书草稿寻求在印度上市",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星国际",
                    "Grand Pharma",
                    "IPO",
                    "印度",
                    "上市"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星医药及复星国际：Grand Pharma在印度提交非正式招股书草稿寻求在印度上市",
            "scores": {
                "News_content": "复星医药及复星国际：Grand Pharma在印度提交非正式招股书草稿寻求在印度上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-10",
            "orginal_text": "上市药企中期业绩陆续出炉 鱼跃医疗等预计增长超100% | 医资周报",
            "features": {
                "keywords": [
                    "上市药企",
                    "中期业绩",
                    "鱼跃医疗",
                    "增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "上市药企中期业绩陆续出炉 鱼跃医疗等预计增长超100% | 医资周报",
            "scores": {
                "News_content": "上市药企中期业绩陆续出炉 鱼跃医疗等预计增长超100% | 医资周报",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-10",
            "orginal_text": "李氏大药厂飙逾22% 拟分拆眼科公司上市",
            "features": {
                "keywords": [
                    "李氏大药厂",
                    "分拆",
                    "眼科公司",
                    "上市"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "眼科"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "李氏大药厂飙逾22% 拟分拆眼科公司上市",
            "scores": {
                "News_content": "李氏大药厂飙逾22% 拟分拆眼科公司上市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-10",
            "orginal_text": "三生制药上涨5.03% 分拆三生国健科创板上市",
            "features": {
                "keywords": [
                    "三生制药",
                    "上涨",
                    "分拆",
                    "三生国健",
                    "科创板",
                    "上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "三生制药上涨5.03% 分拆三生国健科创板上市",
            "scores": {
                "News_content": "三生制药上涨5.03% 分拆三生国健科创板上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]